| Product Code: ETC6180093 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Enteric Disease Testing-Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Enteric Disease Testing-Treatment Market - Industry Life Cycle |
3.4 Australia Enteric Disease Testing-Treatment Market - Porter's Five Forces |
3.5 Australia Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Australia Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.7 Australia Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Testing Technology, 2021 & 2031F |
3.8 Australia Enteric Disease Testing-Treatment Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Australia Enteric Disease Testing-Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of enteric diseases in Australia |
4.2.2 Growing awareness about the importance of early detection and treatment |
4.2.3 Technological advancements in enteric disease testing and treatment methods |
4.3 Market Restraints |
4.3.1 High costs associated with enteric disease testing and treatment |
4.3.2 Limited access to healthcare facilities in remote areas of Australia |
4.3.3 Stringent regulatory requirements for approval of new testing and treatment methods |
5 Australia Enteric Disease Testing-Treatment Market Trends |
6 Australia Enteric Disease Testing-Treatment Market, By Types |
6.1 Australia Enteric Disease Testing-Treatment Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Bacterial Enteric Diseases, 2021- 2031F |
6.1.4 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Viral Enteric Diseases, 2021- 2031F |
6.1.5 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Parasitic Enteric Diseases, 2021- 2031F |
6.2 Australia Enteric Disease Testing-Treatment Market, By Therapeutics |
6.2.1 Overview and Analysis |
6.2.2 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Campylobacter, 2021- 2031F |
6.2.3 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Cryptosporidium, 2021- 2031F |
6.2.4 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By E-Coli, 2021- 2031F |
6.2.5 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Enteroviruses, 2021- 2031F |
6.2.6 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By RhinoViruses, 2021- 2031F |
6.2.7 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By RotaVirus, 2021- 2031F |
6.2.8 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Shigellosis, 2021- 2031F |
6.2.9 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Shigellosis, 2021- 2031F |
6.3 Australia Enteric Disease Testing-Treatment Market, By Testing Technology |
6.3.1 Overview and Analysis |
6.3.2 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.3.3 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.3.4 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Immunoassays, 2021- 2031F |
6.3.5 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Differential Light Scanning, 2021- 2031F |
6.3.6 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Information Technology, 2021- 2031F |
6.3.7 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By AI, 2021- 2031F |
6.3.8 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Flow Cytometry, 2021- 2031F |
6.3.9 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Flow Cytometry, 2021- 2031F |
6.3.10 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Enteric Disease Testing-Treatment Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.4.4 Australia Enteric Disease Testing-Treatment Market Revenues & Volume, By Physician Offices, 2021- 2031F |
7 Australia Enteric Disease Testing-Treatment Market Import-Export Trade Statistics |
7.1 Australia Enteric Disease Testing-Treatment Market Export to Major Countries |
7.2 Australia Enteric Disease Testing-Treatment Market Imports from Major Countries |
8 Australia Enteric Disease Testing-Treatment Market Key Performance Indicators |
8.1 Average turnaround time for enteric disease test results |
8.2 Percentage of population covered by enteric disease testing programs |
8.3 Number of healthcare facilities offering enteric disease testing and treatment |
8.4 Patient satisfaction rates with enteric disease testing and treatment services |
9 Australia Enteric Disease Testing-Treatment Market - Opportunity Assessment |
9.1 Australia Enteric Disease Testing-Treatment Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Australia Enteric Disease Testing-Treatment Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.3 Australia Enteric Disease Testing-Treatment Market Opportunity Assessment, By Testing Technology, 2021 & 2031F |
9.4 Australia Enteric Disease Testing-Treatment Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Australia Enteric Disease Testing-Treatment Market - Competitive Landscape |
10.1 Australia Enteric Disease Testing-Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Enteric Disease Testing-Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here